Company Overview and News

 
Trump Thanks Kanye West for ‘Dragon Energy’ Tweet. Yes, Really - Bloomberg

2018-04-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

1
Cobalt Miners News For The Month Of April 2018

2018-04-25 seekingalpha
Cobalt miner news - South Korea's LG Chem to set up battery material JVs with China's Zhejiang Huayou Cobalt.

1
Cobalt Miners News For The Month Of March 2018

2018-03-25 seekingalpha
Cobalt spot price news - Spot prices rise 18.7% in the past month as inventory falls. The cobalt spot price is now over USD 40/lb, and approaching USD 100,000/tonne.

4
Cobalt Miners News For The Month Of February 2018

2018-02-23 seekingalpha
Cobalt market news - the DRC to hike taxes on Congo cobalt miners. ERG says "cobalt boom ‘guaranteed’ for 7-10 years."

6
Cobalt Miners News For The Month Of January 2018

2018-01-24 seekingalpha
Cobalt spot price news - Cobalt prices up again in January. "BMO Capital Markets expects current cobalt prices to double in the next two years."

2
Cobalt Miners News For The Month Of December 2017

2017-12-22 seekingalpha
Cobalt market news - "Electric vehicle revolution a rare investment opportunity as metals demand spikes." "BMW sees 10-fold jump in its need for battery materials by 2025."

 
Cobalt Miners News For The Month Of November 2017

2017-11-24 seekingalpha
Cobalt miner news - Not a good month for Glencore/Katanga. eCobalt announced their FS results, and Clean TeQ changes their project name from Syerston to Clean TeQ Sunrise project.

1
Cobalt Miners News For The Month Of October 2017

2017-10-24 seekingalpha
Cobalt market news - Auto manufacturers have turned their focus to the raw materials needed to feed the EV boom.

 
Cobalt Miners News For The Month Of September 2017

2017-09-25 seekingalpha
Cobalt market news - "China to ban sale of fossil fuel cars in electric vehicle push."

 
Cobalt Miners News For The Month Of July 2017

2017-07-25 seekingalpha
Cobalt spot price news - Cobalt spot prices rise slightly to reach US$26.54 by June 21. "Market participants anticipate prices to increase by 20-24pc by the end of the year."

 
Cobalt Miners News For The Month Of June 2017

2017-06-25 seekingalpha
Cobalt spot price news - Cobalt spot prices rose strongly to reach US$26.31 by June 22.

 
Top 3 Cobalt Miners To Accumulate

2017-05-16 seekingalpha
Note: This article was first published on my SA Marketplace service on March 24, 2017, so the stock prices and data are as of that date.

 
Cobalt Miner News For April 2017

2017-04-26 seekingalpha
Welcome to the March 2017 cobalt miner news. The focus will be on the cobalt miners that are in, or reasonably near, production, as well as featuring a few promising juniors each month. For a background on the cobalt miners, investors can read my earlier articles:

 
Cobalt Miner News For March 2017

2017-03-27 seekingalpha
Cobalt miner news - Glencore CEO said "in 2018, our overall cobalt production goes into the 50,000 tonnes to 60,000 tonnes range.".

 
Cobalt Miner News For The Month Of February 2017

2017-02-23 seekingalpha
Cobalt market news - Berry: "the demand story around cobalt is real. It appears that a new long-term average price for the material will settle in the $20/lb range.".

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...